Gritstone bio to Participate in Upcoming Investor Conferences
EMERYVILLE, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will be participating in the following investor conferences:
6th Annual Evercore ISI HealthCONx Conference (Fireside Chat)
35th Annual Piper Sandler Healthcare Conference (Fireside Chat)
First Annual Goldman Sachs Catalyst Clinic (Fireside Chat)
Live webcastsof the fireside chats will be available via https://ir.gritstonebio.com/investors/events. Archived replays will be accessible for 30 days following each event.
About Gritstone bio